Showing results (131-140 of 243) with videos related to
Sort By:
Pageof 25
The Lancet Regional Health. Europe|July 23, 2024
Impact of pembrolizumab treatment duration on overall survival and prognostic factors in advanced non-small cell lung cancer: a nationwide retrospective cohort studyAdrien Rousseau, Stefan Michiels, Noémie Simon-Tillaux, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 19, 2026
Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLCSandra Ortiz-Cuaran, Laurine Dupriez, Constance Nicq, et al.Lung Cancer (Amsterdam, Netherlands)|June 27, 2026
New biomarkers for antibody-drug conjugates in lung cancer the pathologist's perspectiveVéronique Hofman, Guylène Rignol, Baharia Mograbi, et al.Cancers|April 12, 2022
Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World BrigALK2 StudyRenaud Descourt, Maurice Pérol, Gaëlle Rousseau-Bussac, et al.Plos One|June 12, 2020
Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assayJordi Remon, Aurelie Swalduz, David Planchard, et al.Endocrine-Related Cancer|July 13, 2013
Are G3 ENETS neuroendocrine neoplasms heterogeneous?Fritz-Line Vélayoudom-Céphise, Pierre Duvillard, Lydia Foucan, et al.Clinical Lung Cancer|June 6, 2022
Clinical Utility and Outcomes Impact of Crystal Digital PCR of Sensitizing and Resistance EGFR Mutations in Patients With Advanced Non-Small Cell Lung CancerMariona Riudavets, Virginie Lamberts, Damien Vasseur, et al.Journal for Immunotherapy of Cancer|November 29, 2024
Antecedent viral immunization and efficacy of immune checkpoint blockade: an extensive serum antibody profile to predict outcomes in non-small cell lung cancerFilippo G Dall'Olio, Wael Salem Zrafi, Quentin Blampey, et al.Clinical Nuclear Medicine|August 10, 2021
Fully Integrated Quantitative Multiparametric Analysis of Non-Small Cell Lung Cancer at 3-T PET/MRI: Toward One-Stop-Shop Tumor Biological Characterization at the Supervoxel LevelFlorent L Besson, Brice Fernandez, Sylvain Faure, et al.Lung Cancer (Amsterdam, Netherlands)|December 2, 2017
Prognostic value of HLA-A2 status in advanced non-small cell lung cancer patientsLaura Mezquita, Melinda Charrier, Laura Faivre, et al.Pageof 25